Vitaliy Ovod

6.2k total citations · 5 hit papers
26 papers, 4.2k citations indexed

About

Vitaliy Ovod is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Vitaliy Ovod has authored 26 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 15 papers in Psychiatry and Mental health and 7 papers in Molecular Biology. Recurrent topics in Vitaliy Ovod's work include Alzheimer's disease research and treatments (21 papers), Dementia and Cognitive Impairment Research (15 papers) and Sleep and Wakefulness Research (4 papers). Vitaliy Ovod is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Dementia and Cognitive Impairment Research (15 papers) and Sleep and Wakefulness Research (4 papers). Vitaliy Ovod collaborates with scholars based in United States, Sweden and United Kingdom. Vitaliy Ovod's co-authors include Randall J. Bateman, Kwasi G. Mawuenyega, John C. Morris, Tom Kasten, Wendy Sigurdson, Kevin E. Yarasheski, Ling Y. Munsell, Tammie L.S. Benzinger, David M. Holtzman and Bruce W. Patterson and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Vitaliy Ovod

25 papers receiving 4.2k citations

Hit Papers

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease 2010 2026 2015 2020 2010 2019 2017 2021 2024 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
    2010 1.6k citations Kwasi G. Mawuenyega, Wendy Sigurdson et al. Science profile →
  2. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
    2019 551 citations Suzanne E. Schindler, James G. Bollinger et al. Neurology profile →
  3. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
    2017 386 citations Vitaliy Ovod, Kwasi G. Mawuenyega et al. Alzheimer s & Dementia profile →
  4. Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
    2021 267 citations Shorena Janelidze, Charlotte E. Teunissen et al. JAMA Neurology profile →
  5. Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
    2024 42 citations Shorena Janelidze, Nicolas R. Barthélemy et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vitaliy Ovod United States 19 2.9k 1.5k 950 940 522 26 4.2k
Simone Lista France 40 2.5k 0.9× 1.6k 1.1× 771 0.8× 1.4k 1.5× 329 0.6× 126 4.7k
Kwasi G. Mawuenyega United States 24 3.9k 1.3× 1.6k 1.1× 1.2k 1.3× 1.7k 1.8× 804 1.5× 34 5.9k
Tom Kasten United States 15 2.2k 0.8× 606 0.4× 765 0.8× 846 0.9× 617 1.2× 19 3.3k
Marc Suárez‐Calvet Spain 37 3.1k 1.0× 1.6k 1.1× 1.8k 1.9× 1.2k 1.3× 685 1.3× 130 5.3k
Katharina Büerger Germany 40 3.4k 1.2× 2.6k 1.8× 1.0k 1.1× 1.2k 1.3× 410 0.8× 87 5.3k
Lutz Froelich Germany 19 1.9k 0.6× 1.4k 1.0× 658 0.7× 777 0.8× 376 0.7× 54 3.9k
Lidia Glodzik United States 32 2.3k 0.8× 1.1k 0.8× 835 0.9× 923 1.0× 926 1.8× 78 4.6k
Debby W. Tsuang United States 35 2.2k 0.7× 1.4k 1.0× 681 0.7× 1.2k 1.3× 683 1.3× 103 4.9k
Vincent Doré Australia 31 2.8k 0.9× 2.2k 1.5× 656 0.7× 788 0.8× 272 0.5× 168 4.4k
Maria Bjerke Belgium 32 2.2k 0.7× 1.8k 1.2× 872 0.9× 1.2k 1.3× 325 0.6× 79 4.2k

Countries citing papers authored by Vitaliy Ovod

Since Specialization
Citations

This map shows the geographic impact of Vitaliy Ovod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vitaliy Ovod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vitaliy Ovod more than expected).

Fields of papers citing papers by Vitaliy Ovod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vitaliy Ovod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vitaliy Ovod. The network helps show where Vitaliy Ovod may publish in the future.

Co-authorship network of co-authors of Vitaliy Ovod

This figure shows the co-authorship network connecting the top 25 collaborators of Vitaliy Ovod. A scholar is included among the top collaborators of Vitaliy Ovod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vitaliy Ovod. Vitaliy Ovod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Janelidze, Shorena, Nicolas R. Barthélemy, Gemma Salvadó, et al.. (2024). Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment. JAMA Neurology. 81(9). 947–947. 42 indexed citations breakdown →
3.
Lucey, Brendan P., Haiyan Liu, Cristina D. Toedebusch, et al.. (2023). Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS. Annals of Neurology. 94(1). 27–40. 46 indexed citations
4.
Wisch, Julie K., Brian A. Gordon, Anna H. Boerwinkle, et al.. (2023). Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(1). e12405–e12405. 14 indexed citations
5.
Barthélemy, Nicolas R., Benjamin Saef, Yan Li, et al.. (2023). CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease. Nature Aging. 3(4). 391–401. 67 indexed citations
6.
Bollinger, James G., Yan Li, Suzanne E. Schindler, et al.. (2022). The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimer s Research & Therapy. 14(1). 195–195. 79 indexed citations
7.
Tosun, Duygu, Dallas P. Veitch, Paul Aisen, et al.. (2021). Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers. Brain Communications. 3(2). fcab008–fcab008. 53 indexed citations
8.
Li, Yan, Suzanne E. Schindler, James G. Bollinger, et al.. (2021). Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology. 98(7). e688–e699. 117 indexed citations
9.
Janelidze, Shorena, Charlotte E. Teunissen, Henrik Zetterberg, et al.. (2021). Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease. JAMA Neurology. 78(11). 1375–1375. 267 indexed citations breakdown →
10.
Panigrahi, Sunil K., Cristina D. Toedebusch, Terry J. Hicks, et al.. (2020). Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption. Journal of Alzheimer s Disease. 75(2). 471–482. 21 indexed citations
11.
Bateman, Randall J., Suzanne E. Schindler, James G. Bollinger, et al.. (2019). F2‐07‐01: BLOOD AMYLOID‐BETA PREDICTS AMYLOID PET CONVERSION. Alzheimer s & Dementia. 15(7S_Part_10). 1 indexed citations
12.
Schindler, Suzanne E., James G. Bollinger, Vitaliy Ovod, et al.. (2019). High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology. 93(17). e1647–e1659. 551 indexed citations breakdown →
13.
Lucey, Brendan P., Terry J. Hicks, Jennifer McLeland, et al.. (2017). Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics. Annals of Neurology. 83(1). 197–204. 252 indexed citations
14.
Ovod, Vitaliy, Kwasi G. Mawuenyega, Terry J. Hicks, et al.. (2017). Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer s & Dementia. 13(8). 841–849. 386 indexed citations breakdown →
15.
Baker‐Nigh, Alaina, Kwasi G. Mawuenyega, James G. Bollinger, et al.. (2016). Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma. Journal of Biological Chemistry. 291(53). 27204–27218. 42 indexed citations
16.
Lucey, Brendan P., Kwasi G. Mawuenyega, Bruce W. Patterson, et al.. (2016). Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System. JAMA Neurology. 74(2). 207–207. 50 indexed citations
17.
Kasten, Tom, Yafei Huang, Tammie L.S. Benzinger, et al.. (2014). Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System. PLoS ONE. 9(3). e89998–e89998. 39 indexed citations
18.
Roberts, Kaleigh F., Donald L. Elbert, Tom Kasten, et al.. (2014). Amyloid‐β efflux from the central nervous system into the plasma. Annals of Neurology. 76(6). 837–844. 203 indexed citations
19.
20.
Mawuenyega, Kwasi G., Wendy Sigurdson, Vitaliy Ovod, et al.. (2010). Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease. Science. 330(6012). 1774–1774. 1637 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Lista Breakdown of academic impact, for papers by Kwasi G. Mawuenyega Breakdown of academic impact, for papers by Tom Kasten Breakdown of academic impact, for papers by Marc Suárez‐Calvet Breakdown of academic impact, for papers by Katharina Büerger Breakdown of academic impact, for papers by Lutz Froelich Breakdown of academic impact, for papers by Lidia Glodzik Breakdown of academic impact, for papers by Debby W. Tsuang Breakdown of academic impact, for papers by Vincent Doré Breakdown of academic impact, for papers by Maria Bjerke
Rankless by CCL
2026